Literature DB >> 30922595

Paying for Frequent Dialysis.

Adam S Wilk1, Richard A Hirth2, Joseph M Messana3.   

Abstract

In late 2017, the 7 regional contractors responsible for paying dialysis claims in Medicare proposed new payment rules that would restrict payment for hemodialysis treatments in excess of 3 weekly to exceptional acute-care circumstances. Frequent hemodialysis is performed more frequently than the traditional thrice-weekly pattern, and many stakeholders-patients, providers, dialysis machine manufacturers, and others-have expressed concern that these payment rules will inhibit the growth of this treatment modality's use among US dialysis patients. In this Perspective, we explain the role of these contractors in the context of Medicare's in-center hemodialysis-centric dialysis payment system and assess how well this system accommodates the higher treatment frequencies of both peritoneal dialysis and frequent hemodialysis. Then, given the available evidence concerning the relative effectiveness of these modalities versus thrice-weekly in-center hemodialysis and trends in their use, we discuss options for modifying Medicare's payment system to support frequent dialysis.
Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hemodialysis (HD); Medicare; Medicare Administrative Contractors (MAC); United States; cost of care; dialysis modality selection; end-stage renal disease (ESRD); home dialysis; home hemodialysis (HHD); payment models; policy; reimbursement rates

Mesh:

Year:  2019        PMID: 30922595      PMCID: PMC7758184          DOI: 10.1053/j.ajkd.2019.01.027

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  54 in total

Review 1.  KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.

Authors: 
Journal:  Am J Kidney Dis       Date:  2015-11       Impact factor: 8.860

2.  Medicare's national coverage decisions for technologies, 1999-2007.

Authors:  Peter J Neumann; Maki S Kamae; Jennifer A Palmer
Journal:  Health Aff (Millwood)       Date:  2008 Nov-Dec       Impact factor: 6.301

3.  Cost of peritoneal dialysis and haemodialysis across the world.

Authors:  Akash Nayak Karopadi; Giacomo Mason; Enrico Rettore; Claudio Ronco
Journal:  Nephrol Dial Transplant       Date:  2013-06-04       Impact factor: 5.992

4.  Selection-adjusted comparison of life-expectancy of patients on continuous ambulatory peritoneal dialysis, haemodialysis, and renal transplantation.

Authors:  P R Burton; J Walls
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

5.  Survival advantage of planned haemodialysis over peritoneal dialysis: a cohort study.

Authors:  Alicia Thiery; François Séverac; Thierry Hannedouche; Cecile Couchoud; Van Huyen Do; Aurélien Tiple; Clémence Béchade; Erik-Andre Sauleau; Thierry Krummel
Journal:  Nephrol Dial Transplant       Date:  2018-08-01       Impact factor: 5.992

6.  Cost savings of home nocturnal versus conventional in-center hemodialysis.

Authors:  Philip A McFarlane; Andreas Pierratos; Donald A Redelmeier
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

7.  Comparison of quality of life of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and after transplantation.

Authors:  R G Simmons; C Anderson; L Kamstra
Journal:  Am J Kidney Dis       Date:  1984-11       Impact factor: 8.860

8.  Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years.

Authors:  Carl M Kjellstrand; Umberto Buoncristiani; George Ting; Jules Traeger; Giordina B Piccoli; Roula Sibai-Galland; Bessie Ann Young; Christopher R Blagg
Journal:  Nephrol Dial Transplant       Date:  2008-05-05       Impact factor: 5.992

9.  Why patients with ESRD do not select self-care dialysis as a treatment option.

Authors:  Kevin McLaughlin; Braden Manns; Garth Mortis; Ronald Hons; Ken Taub
Journal:  Am J Kidney Dis       Date:  2003-02       Impact factor: 8.860

10.  Hospice characteristics and the disenrollment of patients with cancer.

Authors:  Melissa D A Carlson; Jeph Herrin; Qingling Du; Andrew J Epstein; Emily Cherlin; R Sean Morrison; Elizabeth H Bradley
Journal:  Health Serv Res       Date:  2009-07-27       Impact factor: 3.402

View more
  3 in total

1.  Hidden Costs Associated with Conversion from Peritoneal Dialysis to Hemodialysis.

Authors:  Eric D Weinhandl; Tonya L Saffer; Michael Aragon
Journal:  Kidney360       Date:  2022-03-02

2.  Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.

Authors:  Rui Wu; Fan Wei; Lianlian Qu; Litao Bai; Jun Li; Fei Li; Weitian Yan; Qiuhong Wang; Junping Wei
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

3.  Home Hemodialysis: Bending the Utilization Curve With Novel Strategies.

Authors:  Page Salenger
Journal:  Kidney Med       Date:  2019-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.